Related Experiment Videos
Seaweed prevents breast cancer?
1Department of Surgery II, Nagoya University School of Medicine, Showa-ku, Nagoya 466-8550, Japan. hfunahas@tsuru.med.nagoya-u.ac.jp
Japanese Journal of Cancer Research : Gann
|May 30, 2001
Summary
Mekabu, a type of seaweed, demonstrated potent breast cancer chemoprevention by inducing apoptosis in cancer cells without harming normal cells. This safe, edible food shows promise for preventing human breast cancer.
Area of Science:
- Oncology
- Marine Biology
- Nutritional Science
Background:
- Seaweed, particularly wakame, has shown potential in suppressing mammary tumor proliferation.
- Iodine's role in breast cancer is an area of ongoing investigation.
- Mekabu is a commonly consumed seaweed in Japan with a favorable safety profile.
Purpose of the Study:
- To evaluate the chemopreventive effects of mekabu on breast cancer.
- To investigate mekabu's mechanism of action, specifically apoptosis induction.
- To compare mekabu's efficacy against a standard chemotherapeutic agent.
Main Methods:
- Mekabu was prepared as an aqueous solution.
- The solution was administered to rats with dimethylbenz(a)anthracene-induced mammary tumors.
- In vitro studies used human breast cancer cell lines and normal mammary cells.
Main Results:
- Mekabu solution significantly suppressed rat mammary carcinogenesis without observed toxicity.
- Mekabu induced apoptosis in three types of human breast cancer cells.
- The apoptotic effect of mekabu was superior to a widely used chemotherapeutic agent and did not affect normal mammary cells.
Conclusions:
- Mekabu exhibits potent, selective apoptosis-inducing properties against breast cancer cells.
- Mekabu demonstrates significant potential as a chemopreventive agent for human breast cancer.
- The findings support the traditional consumption of mekabu as a safe and potentially therapeutic food.